Announcement
21 Aug 2020
In August 2020, the Norwegian authorities introduced an export notification on certain immunoglobulins following the outbreak of COVID-19.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
21 Aug 2020
Revocation date:
03 Mar 2021
Updated: 21 Aug 2020
Export licensing requirement
On 21 August 2020, the Norwegian Medicines Agency introduced an export notification on immunoglobulins as so far as it related to immunoglobulins in the following doses: Hizentra 200 mg/ml, 20 ml h...
Sign in to see more
Related State Acts
03 Mar 2021
Norway: Introduction and subsequent removal of export ban on all immunoglobulins
01 Oct 2020
Norway: Introduction of export notification on all types of immunoglobulins following the outbreak of COVID-19
29 Jul 2020
Norway: Introduction of export ban on rivaroxaban, apixaban, immunoglobulins and palivizumab (COVID-19)
Threads
See all
This state act is not part of any Thread yet.